|Mr. Vivek Jain||Chairman & Chief Exec. Officer||1.6M||N/A||45|
|Mr. Scott E. Lamb||CFO & Treasurer||748.21k||5.45M||54|
|Mr. Steven C. Riggs||Corp. VP of Operations||683.56k||6.65M||58|
|Mr. Thomas D. McCall||Corp. VP of Marketing & Communications and GM of Critical Care||535.05k||1.4M||59|
|Ms. Alison D. Burcar||Corp. VP & GM of Infusion Consumables||584.62k||N/A||45|
ICU Medical, Inc. develops, manufactures, and sells medical devices used in infusion therapy, critical care, and oncology applications worldwide. It offers infusion therapy products comprising a tube running from a bottle or plastic bag containing a solution to a catheter inserted in a patients vein for use in hospitals and ambulatory clinics. The companys infusion therapy products include needlefree connector products, such as MicroClave and MicroClave Clear, Neutron, NanoClave, Clave, and SwabCap; custom infusion sets; and Tego needlefree hemodialysis connectors. It also provides critical care products that are used to monitor signs, as well as physiological functions of organ systems. The companys critical care products comprises hemodynamic monitoring systems and SafeSet closed blood sampling and conservation systems, as well as sensing catheters, Lopez Valve, and cables and accessories for hemodynamic monitoring. In addition, it offers a line of oncology products, which are used to prepare and deliver hazardous medications for use in chemotherapy, such as ChemoLock and ChemoClave closed system transfer devices and components, and Diana hazardous drug compounding systems. The company sells its products to medical product manufacturers, distributors, and end-users. ICU Medical, Inc. was founded in 1984 and is headquartered in San Clemente, California.
ICU Medical, Inc.’s ISS Governance QualityScore as of July 1, 2017 is 6. The pillar scores are Audit: 2; Board: 5; Shareholder Rights: 9; Compensation: 3.